12:00 AM
Feb 04, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Qiagen, General Electric sales and marketing update

Qiagen said General Electric's Clarient Diagnostic Services Inc. company will now offer Qiagen's therascreen KRAS RGQ PCR Kit as a companion diagnostic to Erbitux cetuximab for metastatic colorectal cancer (mCRC). The PCR-based test detects mutations in codons 12 and 13 of the

Read the full 219 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >